Conversely, activation of IL-1R1 in renal endothelial cells improves aristolochic acid (AA)-induced AKI by restoring vascular endothelial growth factor A (VEGFA)-dependent endothelial cell viability and density [62]. The gene discussed is IL1R1; the disease is acute kidney injury.